WC
www.cyrontp.com
The startup is developing a T-cell active bispecific antibody treatment specifically targeting pancreatic cancer, utilizing a novel platform to enhance immune response against solid tumors. This approach aims to improve treatment efficacy for patients facing this challenging and often lethal form of cancer.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup is developing a T-cell active bispecific antibody treatment specifically targeting pancreatic cancer, utilizing a novel platform to enhance immune response against solid tumors. This approach aims to improve treatment efficacy for patients facing this challenging and often lethal form of cancer.